All Posts By

Smartkarma Daily Briefs

Daily Brief Industrials: Samsung KODEX Semicon ETF, Otis Worldwide , Curtiss Wright, Tetra Tech Inc, Verisk Analytics, Watts Water Technologies A, Synergy Green Industries and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Clarifying the Universe for Key Korean Index Rebalancings in September
  • Otis CEO: Moving Billions Daily, Elevator Evolution, and Service Excellence
  • Curtiss-Wright: Commercial Aerospace Opportunities As A Key Growth Catalyst!
  • Tetra Tech: Will Its Investments In Infrastructure & Water Management Projects Yield Results…
  • Verisk Analytics: Adaptation to Market Conditions, M&A Focus & Other Major Developments!
  • Watts Water Technologies: Vertical Integration & U.S.-Based Manufacturing to Capitalize On Its Competitive Advantages In Manufacturing & Distribution!
  • Synergy Green Industries Q4 FY25 Update: Capacity Expansion Fuels Strong FY25


Clarifying the Universe for Key Korean Index Rebalancings in September

By Sanghyun Park

  • KRX sector indices use TMI as their universe, while KOSPI cap-tier indices use all KOSPI-listed stocks, creating a key difference in universe selection.
  • KRX sector indices rebalance annually after September expiry, using September TMI (reviewed end-July) as their universe—not the June version, despite common confusion.
  • Pre-Positioning is uncertain; market likely waits for August’s September TMI results before building positions. KOSPI cap indices use August review date, with similar flow patterns starting six weeks prior.

Otis CEO: Moving Billions Daily, Elevator Evolution, and Service Excellence

By In Good Company with Nicolai Tangen

  • Passenger experience is key for elevators, focusing on ride quality and safety
  • Elevators should prioritize moving people quickly and efficiently
  • The elevator industry is highly consolidated with few major competitors and regulations play a significant role in the industry

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Curtiss-Wright: Commercial Aerospace Opportunities As A Key Growth Catalyst!

By Baptista Research

  • Curtiss-Wright’s first quarter 2025 earnings results reveal a robust start to the year, driven by both increased sales and operational efficiency.
  • The company reported a 13% year-over-year increase in sales to $806 million, with an 11% rise on an organic basis.
  • This growth was primarily fueled by stronger-than-expected performance in the Aerospace and Defense (A&D) markets.

Tetra Tech: Will Its Investments In Infrastructure & Water Management Projects Yield Results…

By Baptista Research

  • The latest earnings for Tetra Tech presented a mix of positive developments and notable challenges, providing investors with a nuanced view of the company’s current financial health and strategic direction.
  • The quarter was extraordinary in terms of revenue and profitability, achieved despite the unexpected loss of the largest client, which marks a significant test for Tetra Tech’s client diversification strategy.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Verisk Analytics: Adaptation to Market Conditions, M&A Focus & Other Major Developments!

By Baptista Research

  • Verisk Analytics (Verisk) has demonstrated a positive start to 2025, with a notable performance in the first quarter.
  • The company saw double-digit growth in subscription revenues, contributing to an overall organic constant currency (OCC) revenue increase of 7.9%.
  • This growth was propelled by a 10.6% rise in subscription revenues, reflecting strength across multiple business units within the company.

Watts Water Technologies: Vertical Integration & U.S.-Based Manufacturing to Capitalize On Its Competitive Advantages In Manufacturing & Distribution!

By Baptista Research

  • Watts Water Technologies reported its first quarter results for 2025, which showed a mix of positive achievements and ongoing challenges.
  • The company experienced record operating income and operating margins, along with adjusted earnings per share.
  • Despite these results, organic sales declined by 2%, impacted by fewer shipping days and weakness in the European market.

Synergy Green Industries Q4 FY25 Update: Capacity Expansion Fuels Strong FY25

By Sudarshan Bhandari

  • Synergy Green reported robust FY25 performance with 11% revenue growth and 224bps EBITDA margin expansion, driven by direct exports and gearboxes.  
  • Strong execution and margin improvement underscore operational efficiency, while a significant INR 187 crore capex addresses capacity constraints, crucial for future growth.
  • Performance validates the business model, but the delayed capex execution means FY26 growth will be heavily back-ended, requiring close monitoring of ramp-up.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: Sasseur REIT and more

By | Daily Briefs, Singapore

In today’s briefing:

  • Smartkarma Corporate Webinar | Sasseur REIT: Unlocking Value in China’s Retail Outlet Industry


Smartkarma Corporate Webinar | Sasseur REIT: Unlocking Value in China’s Retail Outlet Industry

By Smartkarma Research

For our next Corporate Webinar we are glad to welcome Sasseur REIT’s CFO, Mr. Xie Jianfeng, Head of Asset Management, Mr. Cheng Hsing Yuen, and Head of Investor Relations & Capital Markets, Ms. Helen Qiu.

In the upcoming webinar, the Sasseur REIT team will share a short company presentation after which, they will engage in a fireside chat with Smartkarma Insight Provider, Garreth Elston. The Corporate Webinar will include a live Q&A session.

The Corporate Webinar will be hosted on Wednesday, 25 June 2025, 16:30 SGT.

About Sasseur REIT

Sasseur REIT is the first retail outlet mall REIT listed in Asia. Sasseur REIT offers investors
the unique opportunity to invest in the fast-growing retail outlet mall sector in China through
its initial portfolio of four quality retail outlet mall assets strategically located in fast-growing
Chinese cities such as Chongqing, Kunming and Hefei, with a combined net lettable area of
310,241 square metres.

Sasseur REIT is established with the investment strategy to invest principally, directly or
indirectly, in a diversified portfolio of income-producing real estate which is used primarily for
retail outlet mall purposes, as well as real estate-related assets in relation to the foregoing,
with an initial focus on Asia.

You can view their latest factsheet here.

For more information on Sasseur REIT, please visit http://www.sasseurreit.com/


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: GMO Financial Gate, NVIDIA Corp, Gamma Communications, Hewlett Packard Co, Skyworks Solutions, Shift Inc, Global Fashion Group SA, Cdw Corp/De, IonQ , Unity Software and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • [Quiddity Index] GMO (9449) Sub GMO Financial Gate (4051) Moves to TOPIX
  • NVIDIA Q126. China Restrictions Bring QoQ Growth Screeching To A Halt
  • Quiddity Leaderboard F100/F250 Jun25: LONGs up +6% Vs Index; Multiple Intra-Review Changes Soon
  • PC Monitor: Commercial PC Demand Resilient; AI PC Momentum Builds W/ NVDA Blackwell-Powered Launches
  • Skyworks Solutions: Its RF Expertise In The 5G Era Is Probably Its Single Biggest Competitive Edge! – Major Drivers
  • Shift: Shift in Recruitment Policy Supports Margin Recovery; Further Upside
  • Global Fashion Group — Refined and redefined
  • CDW Corporation: A Closer Look At Its End-Market Growth & Diversification & Other Major Drivers!
  • IonQ’s $8.75 Billion Dream Collides With Doubts: Can Acquisitions Outpace Losses?
  • Unity Software: These Are The 6 Biggest Factors Impacting Its Performance In 2025 & Beyond!


[Quiddity Index] GMO (9449) Sub GMO Financial Gate (4051) Moves to TOPIX

By Travis Lundy


NVIDIA Q126. China Restrictions Bring QoQ Growth Screeching To A Halt

By William Keating

  • NVIDIA reported Q1FY26 revenues of $44.1 billion, up 69% YoY and up 12% QoQ
  • NVIDIA forecasted current quarter revenues of $45.0 billion, marginally up QoQ and weighed down by the loss of around $8 billion in previously anticipated H20 revenues
  • Does China really wish to remain reliant on US infrastructure/platforms for its AI build out indefinitely? I think not. Gradually losing China market was inevitable, even without US restrictions.

Quiddity Leaderboard F100/F250 Jun25: LONGs up +6% Vs Index; Multiple Intra-Review Changes Soon

By Janaghan Jeyakumar, CFA

  • In this insight, we take a look at the potential index changes for F100 and F250 in the run-up to the June 2025 index rebal event.
  • We see one M&A-related intra-review change for the F250 index prior to the June 2025 review and then one more shortly after the rebal event.
  • Our latest estimates suggest there could be four regular changes for the F250 index during the June 2025 rebalance. We do not currently see any changes for the F100.

PC Monitor: Commercial PC Demand Resilient; AI PC Momentum Builds W/ NVDA Blackwell-Powered Launches

By Vincent Fernando, CFA

  • HP Results Show Commercial PC Growth is Resilient, AI PC Penetration Expanding
  • Key Industry Outlook Perspective — HP’s ZGX AI Station with NVIDIA Chips Marks the True Arrival of AI PCs… Locally Run LLMs Signal a Step-Change for PC Capabilities
  • Remain Structurally Long PC Makers on AI PC Upgrade Cycle — Emergence of New NVIDIA Blackwell-Powered Workstations Clarifying the Path for AI PCs to Deliver Step-Change Improvements in Value

Skyworks Solutions: Its RF Expertise In The 5G Era Is Probably Its Single Biggest Competitive Edge! – Major Drivers

By Baptista Research

  • Skyworks Solutions reported its second fiscal quarter 2025 results, highlighting both strengths and challenges within its operational landscape.
  • The company delivered revenue of $953 million and earnings per share of $1.24, both slightly exceeding the midpoint of their guidance.
  • Gross profit was $445 million, with a gross margin of 46.7%, indicating strong execution in cost management and operational efficiency.

Shift: Shift in Recruitment Policy Supports Margin Recovery; Further Upside

By Shifara Samsudeen, FCMA, CGMA

  • Shift’s share price has been up by more than 35% YTD driven by improved margins which saw a temporary decline due to Shift’s investment on HR and system reinforcement.
  • The company’s GPM reached an all-time high in 2QFY08/2025 while OPM has shown significant improvement driven by the company’s changes to recruitment policy that is aligned to utilisation rates.
  • Though Shift’s top line growth has slowed down, it’s not something to worry too much about as its new businesses and large-scale project wins should help revive top line growth.

Global Fashion Group — Refined and redefined

By Edison Investment Research

Global Fashion Group (GFG) operates leading fashion and lifestyle platforms that enable brands to reach customers in a mix of developed and developing markets with high growth potential. Management has responded to industry-wide competitive and macroeconomic challenges by focusing its geographic coverage and refining its product offer and customer engagement, which is leading to more encouraging trends in customer numbers and spend per customer. This gives management confidence to guide to a significant increase in profitability in the medium term, to levels comparable with its peers. This is significant given GFG’s low absolute enterprise value, with a market capitalisation broadly similar to its net cash position including leases and low multiples versus its peers.


CDW Corporation: A Closer Look At Its End-Market Growth & Diversification & Other Major Drivers!

By Baptista Research

  • The earnings for CDW Corporation’s first quarter of 2025 highlights several key aspects of its performance and outlook.
  • With detailed comments from management, the company presents a mixed set of results and expectations amid a dynamic market environment.
  • Starting with the positives, CDW reported a robust start to the year with net sales increasing by 8% year-over-year to $5.2 billion.

IonQ’s $8.75 Billion Dream Collides With Doubts: Can Acquisitions Outpace Losses?

By Baptista Research

  • IonQ’s latest financial results and strategic developments signal a bold push toward cementing its role as a dominant player in the emerging quantum computing industry.
  • The company reported first-quarter revenue of $7.6 million, matching last year’s figure but exceeding analyst expectations.
  • Despite the flat top-line performance, IonQ remains aggressive in its vision to become the “Nvidia of quantum computing,” as CEO Niccolo de Masi described.

Unity Software: These Are The 6 Biggest Factors Impacting Its Performance In 2025 & Beyond!

By Baptista Research

  • Unity Technologies recently reported their earnings, presenting both its positive strides and current challenges in the first quarter of 2025.
  • The company’s results exceeded expectations in several areas, notably in revenue and adjusted EBITDA, surpassing high-end guidance by 5% and 29% respectively.
  • The company attributed this growth to its unified efforts in the Grow and Create segments, both of which exhibited considerable strength.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Xuanzhu Biopharmaceutical, Omada Health, Elanco Animal Health , Immix Biopharma Inc, Aster DM Healthcare Ltd, Telomir Pharmaceuticals, Mckesson Corp, Bio Techne Corp and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Xuanzhu Biopharm (轩竹生物科技) Pre-IPO: Reality Checks Against Claims
  • Omada Health (OMDA): Second Virtual Healthcare Provider Ready to Test the IPO Market
  • Elanco Animal Health: The Commercialization of Zenrelia & Its Expansion in Farm Animal Sector Are Upping The Game!
  • Immix Biopharma — Positive newsflow continues for NEXICART-2
  • 2025 High Conviction Update: Aster DM(ASTERDM IN)-Occupancy to Recover; Margin Improvement Continues
  • TELO: Exciting News for AMD Sufferers
  • McKesson’s Bold Growth Play: 3,300 Providers, AI Investments, & Soaring GLP-1 Revenues!
  • Bio-Techne Corporation: An Insight Into The Pharmaceutical Market Dynamics & China’s Economic & Regulatory Environment!


Xuanzhu Biopharm (轩竹生物科技) Pre-IPO: Reality Checks Against Claims

By Ke Yan, CFA, FRM

  • Xuanzhu Biopharm, the biotech arm of HK-listed Sihuan Pharma, is seeking to raise at least USD 100m via a Hong Kong listing. The sole sponsor is CICC.
  • In this insight, we look at the company’s core products and key products, including XBP-3571, XZP-3287 and XZP-3621.
  • While there are some interesting reads from its clinical data, we are of the view that its near-commercial products are still lacking the differentiating factors in respective competitive therapeutic areas.

Omada Health (OMDA): Second Virtual Healthcare Provider Ready to Test the IPO Market

By IPO Boutique

  • After the success of Hinge Health, Omada Health is now testing the IPO waters. 
  • Omada Health set terms with the SEC on Thursday morning for its IPO and will offer 7.9mm shares at $18-$20 with a debut date of Friday, June 6th. 
  • The size of the transaction is manageable and the company is backed by major VC players in the industry. 

Elanco Animal Health: The Commercialization of Zenrelia & Its Expansion in Farm Animal Sector Are Upping The Game!

By Baptista Research

  • Elanco Animal Health reported its financial performance for the first quarter of 2025, revealing several key aspects of its operational and strategic positioning.
  • The company outperformed its expectations in revenue, adjusted EBITDA, and adjusted EPS, marking a continuation of its growth trajectory.
  • A significant achievement was a 4% organic constant currency revenue growth, underpinned equally by price and volume increases.

Immix Biopharma — Positive newsflow continues for NEXICART-2

By Edison Investment Research

Immix Biopharma has announced a positive clinical update for the US-based Phase I/II NEXICART-2 trial, investigating lead CAR-T candidate NXC-201 as a potential treatment for relapsed/refractory (r/r) amyloid light chain amyloidosis (ALA). These interim results show that, at the data cut off of 28 January 2025, five out of seven (71%) patients had shown a complete response (CR). Furthermore, no relapses or safety concerns have been reported to date, consistent with Immix’s goal of making NXC-201 the first ‘outpatient’ CAR-T therapy. We view this latest update as encouraging for the NEXICART-2 trial, though we acknowledge that the data still correspond to a relatively small population. A more detailed presentation is due to be presented at the 2025 American Society of Clinical Oncology Annual Meeting (ASCO 2025) on 3 June. Immix is also hosting a key opinion leader (KOL) event later the same day to discuss clinical experiences with NXC-201, as well as the evolving treatment landscape for r/r ALA. Separately, Immix also announced that NEXICART-2 now has 14 active US sites (10 more than the company’s prior update) and that it anticipates completing the trial ahead of schedule.


2025 High Conviction Update: Aster DM(ASTERDM IN)-Occupancy to Recover; Margin Improvement Continues

By Tina Banerjee

  • Aster DM Healthcare Ltd (ASTERDM IN) reported 4% revenue decline in Kerala due to festivities, lower international patient, and leadership transition. Ramadan impact caused 2.5–3.0% of the revenue hit.
  • Going ahead, the company is eyeing for atleast mid-teens growth from Kerala cluster, with 7–8% will be with volumes and balance 7–8% will come from the ARPOB.  
  • Aster’s base business is on a stable growth path. Margin levers are intact. With QCIL merger synergies, the company aims for EBITDA margin of 23–24% in 3–4 years.

TELO: Exciting News for AMD Sufferers

By Zacks Small Cap Research

  • Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend human lifespans and improve quality of life as people age.
  • The company announced preclinical test results that showed Telomir-1 restored vision and retinal structure in Age-Related Macular Degeneration in an animal model-an encouraging result for millions of AMD sufferers.

McKesson’s Bold Growth Play: 3,300 Providers, AI Investments, & Soaring GLP-1 Revenues!

By Baptista Research

  • McKesson Corporation reported robust financial results for its fourth quarter and fiscal year 2025, showing considerable progress and strategic advancement.
  • The company’s consolidated revenue grew significantly by 16% year-over-year, reaching a record $359 billion.
  • Adjusted earnings per diluted share came in at $33.05, a 20% increase compared to the previous year, surpassing long-term growth targets of 12% to 14%.

Bio-Techne Corporation: An Insight Into The Pharmaceutical Market Dynamics & China’s Economic & Regulatory Environment!

By Baptista Research

  • Bio-Techne reported its third-quarter fiscal year 2025 results, exhibiting a strong performance despite navigating a challenging macroeconomic environment.
  • The company achieved 6% organic revenue growth, underscoring its resilience in the face of various uncertainties and highlighting the importance of its diversified product portfolio, including core reagents, automated analytical solutions, and cell and gene therapy offerings.
  • This growth was achieved while maintaining a robust adjusted operating margin of 34.9%, facilitated by strategic investments in operational efficiencies.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: SBI Sumishin Net Bank , Sasseur REIT, HDFC Bank, Alpha Bank AE, Industrial Bank Of Korea, USD, Indusind Bank and more

By | Daily Briefs, Financials

In today’s briefing:

  • [Japan M&A] NTT To Buy Out SBI Sumishin Net Bank (7163) At a HUGE Price for Minorities
  • Smartkarma Corporate Webinar | Sasseur REIT: Unlocking Value in China’s Retail Outlet Industry
  • SBI Sumishin Net Bank (7163 JP): NTT’s (9432 JP) JPY4,900 Tender Offer a Done Deal
  • NIFTY Bank Index: Impact of the Forecast Methodology Change
  • Alpha Accumulation: UniCredit’s Strategic Wedge in Greek Banking
  • Industrial Bank Of Korea (024110 KS) Vs. Woori Financial (316140 KS): Pair Trade Signal
  • HDFC Bank Tactical View: Inflection Point or Just a Pause?
  • HDFC Bank (“HDFCB”): Steady Performance in Line with Expectation
  • Global FX & Global Rates: Term premia rising: implications for rates and FX
  • A Deep Dive into SEBI’s IndusInd Bank Insider Trading Order


[Japan M&A] NTT To Buy Out SBI Sumishin Net Bank (7163) At a HUGE Price for Minorities

By Travis Lundy

  • Late Nov-2024, SBI Sumishin Net Bank (7163 JP) was trading ¥2,900, weekly mag Bunshun scooped a possible NTT Docomo deal. The stock popped, I was skeptical. It popped more.
  • At Q3 earnings, NTT seemed to downplay the possibility saying they wouldn’t overpay. SBI Sumshin fell. Then fell some more. 
  • Today we get a deal whereby NTT buys out SBI Holdings (8473 JP)‘s 34% stake, and minorities, and partners with Sumitomo Mitsui Trust. Then a side deal with SBI. 

Smartkarma Corporate Webinar | Sasseur REIT: Unlocking Value in China’s Retail Outlet Industry

By Smartkarma Research

For our next Corporate Webinar we are glad to welcome Sasseur REIT’s CFO, Mr. Xie Jianfeng, Head of Asset Management, Mr. Cheng Hsing Yuen, and Head of Investor Relations & Capital Markets, Ms. Helen Qiu.

In the upcoming webinar, the Sasseur REIT team will share a short company presentation after which, they will engage in a fireside chat with Smartkarma Insight Provider, Garreth Elston. The Corporate Webinar will include a live Q&A session.

The Corporate Webinar will be hosted on Wednesday, 25 June 2025, 16:30 SGT.

About Sasseur REIT

Sasseur REIT is the first retail outlet mall REIT listed in Asia. Sasseur REIT offers investors
the unique opportunity to invest in the fast-growing retail outlet mall sector in China through
its initial portfolio of four quality retail outlet mall assets strategically located in fast-growing
Chinese cities such as Chongqing, Kunming and Hefei, with a combined net lettable area of
310,241 square metres.

Sasseur REIT is established with the investment strategy to invest principally, directly or
indirectly, in a diversified portfolio of income-producing real estate which is used primarily for
retail outlet mall purposes, as well as real estate-related assets in relation to the foregoing,
with an initial focus on Asia.

You can view their latest factsheet here.

For more information on Sasseur REIT, please visit http://www.sasseurreit.com/


SBI Sumishin Net Bank (7163 JP): NTT’s (9432 JP) JPY4,900 Tender Offer a Done Deal

By Arun George

  • SBI Sumishin Net Bank (7163 JP) has recommended a tender offer from NTT (Nippon Telegraph & Telephone) (9432 JP) at JPY4,900 per share, a 23.0% premium to the last close.
  • Irrevocables from the two largest shareholders, representing a 68.38% ownership ratio, ensure a done deal as it exceeds the required 66.67% ownership ratio to pass the EGM share consolidation vote.
  • The offer is attractive compared to historical trading ranges and peer multiples. The tender offer runs from 30 May to 10 July (30 business days).

NIFTY Bank Index: Impact of the Forecast Methodology Change

By Brian Freitas

  • To reduce index concentration and the risk of market volatility and market manipulation, SEBI has recommended changes to the eligibility criteria for derivatives on non-benchmark indices.
  • The recommended changes will result in two inclusions to the NSE Nifty Bank Index (NSEBANK INDEX) along with large capping changes.
  • The inclusions and capping changes will result in an estimated one-way turnover of 17.05% and in a round-trip trade of INR 76.2bn (US$893m) in September.

Alpha Accumulation: UniCredit’s Strategic Wedge in Greek Banking

By Jesus Rodriguez Aguilar

  • Strategic Investment with High Returns: UniCredit’s acquisition of a 9.7% stake in Alpha Bank at a forward P/E of 7.5x, compared to UniCredit’s 8.8x, offers a non-dilutive, high-return investment opportunity.
  • Optionality for Control: UniCredit has signaled it will seek regulatory approval to raise its Alpha stake to 29.9%, enhancing strategic influence and potentially paving the way for future M&A integration.
  • Options strategy: Investors can consider a long call spread strategy on Alpha Bank’s stock, leveraging potential upside from UniCredit’s increased stake while limiting downside risk through defined strike prices.

Industrial Bank Of Korea (024110 KS) Vs. Woori Financial (316140 KS): Pair Trade Signal

By Gaudenz Schneider

  • The Industrial Bank Of Korea (024110 KS)/ Woori Financial Group (316140 KS) price-ratio has deviated more than two standard deviations from its one-year average, presenting a potential relative value opportunity.
  • The relative value opportunity can be implemented through stocks, derivatives, or as relative over-/underweights in a long only context.
  • This Insight discusses trade setup, statistical properties, factor exposure, and risk management strategies.

HDFC Bank Tactical View: Inflection Point or Just a Pause?

By Nico Rosti

  • HDFC Bank (HDFCB IN) is navigating a mix of positive growth indicators and emerging regulatory challenges but average 12-month target is ₹2,194, with estimates ranging from ₹1,627 to ₹2,793.
  • Consensus rating: predominantly “Buy” from major brokerages, including ICICI Securities and Motilal Oswal, citing strong loan growth and stable asset quality.
  • The stock’s strong fundamentals and growth outlook remain intact, but momentum has stalled in recent weeks following the sharp rally we correctly anticipated from January 14, 2025.

HDFC Bank (“HDFCB”): Steady Performance in Line with Expectation

By Ankit Agrawal, CFA

  • In Q4FY25, deposits grew strong at 15.8% YoY. QoQ, average deposits grew by 3.1%. Time deposits led the growth while growth in CASA deposits was relatively muted.
  • In line with its stated strategy, HDFCB’s loan book has been growing slower than that of deposits to bring down the credit-deposit ratio. Average AUM grew 7.3% YoY in Q4FY25.
  • Credit-Deposit ratio is now at 96% vs 110% at merger. Going forward, the adjustment in credit-deposit ratio won’t be as steep, thus FY26 is expected to be a normalization year.

Global FX & Global Rates: Term premia rising: implications for rates and FX

By At Any Rate

  • There is a supply demand mismatch globally, particularly at the long end of the curve
  • Rising term premiums are a concern, especially in the US due to fiscal uncertainty
  • While the speed of the recent moves is notable, there are no major financial stability concerns in the US, but Japan may need to take action to address volatility in the super long sector

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


A Deep Dive into SEBI’s IndusInd Bank Insider Trading Order

By Nimish Maheshwari

  • SEBI’s order against IndusInd Bank’s ex-CEO and others reveals a 15-month deliberate delay in disclosing critical accounting discrepancies.
  • This exposes severe corporate governance failures, eroding investor trust due to alleged insider trading.
  • SEBI fined the company with the INR 20Crs. to IndusInd officials as well as also barred the senior officials from dealing in security market.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: SHEIN, Miniso, Xuanzhu Biopharmaceutical and more

By | China, Daily Briefs

In today’s briefing:

  • Shein IPO: Hong Kong Yes, London No
  • [Miniso(MNSO US, SELL, TP US$13.5) TP Change]: C1Q25 Review: Low Quality Expansion Bore Bitter Fruit
  • Xuanzhu Biopharm (轩竹生物科技) Pre-IPO: Reality Checks Against Claims


Shein IPO: Hong Kong Yes, London No

By Douglas Kim

  • Shein announced it is planning for an IPO in Hong Kong in 2025. Shein tried to go public in London, but its attempt has essentially failed. 
  • Due to tariff war and ending de minimis for shipments from China and Hong Kong by the U.S. government, the valuation of Shein could decline to less than $50 billion.
  • Now, as long as the valuation is not excessive but reasonable, there could be a decent demand for this IPO of Shein in Hong Kong. 

[Miniso(MNSO US, SELL, TP US$13.5) TP Change]: C1Q25 Review: Low Quality Expansion Bore Bitter Fruit

By Eric Wen

  • MNSO reported 1Q25 rev. in line with cons. but non-GAAP op. profit 17% below and GAAP net income 33% below cons, 
  • We view MNSO’s store expansion as being below its bar of quality. Downside risks were not fully priced in. Our 2025 revenue/net profit forecasts are 7.0%/8.2% below consensus;
  • We cut the TP from US$16 to US$13.5/ADS and keep the SELL rating.

Xuanzhu Biopharm (轩竹生物科技) Pre-IPO: Reality Checks Against Claims

By Ke Yan, CFA, FRM

  • Xuanzhu Biopharm, the biotech arm of HK-listed Sihuan Pharma, is seeking to raise at least USD 100m via a Hong Kong listing. The sole sponsor is CICC.
  • In this insight, we look at the company’s core products and key products, including XBP-3571, XZP-3287 and XZP-3621.
  • While there are some interesting reads from its clinical data, we are of the view that its near-commercial products are still lacking the differentiating factors in respective competitive therapeutic areas.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: SBI Sumishin Net Bank , GMO Financial Gate, Isuzu Motors, Mazda Motor, Nippon Steel Corporation, Shift Inc, Migalo Holdings and more

By | Daily Briefs, Japan

In today’s briefing:

  • [Japan M&A] NTT To Buy Out SBI Sumishin Net Bank (7163) At a HUGE Price for Minorities
  • [Quiddity Index] GMO (9449) Sub GMO Financial Gate (4051) Moves to TOPIX
  • [Japan ECM] Financial Crossholders Offering Isuzu (7202) – Big Buyback Covers Most Of The Back End
  • Isuzu Motors Placement – Relatively Small Deal Along with Buyback
  • SBI Sumishin Net Bank (7163 JP): NTT’s (9432 JP) JPY4,900 Tender Offer a Done Deal
  • CIT Saves the World from Tariffs, but Not Mazda (7261)
  • Nippon Steel (5401 JP): Navigating Decline at Home, Expanding Abroad
  • Shift: Shift in Recruitment Policy Supports Margin Recovery; Further Upside
  • Migalo Holdings (5535 JP) – Q4 Follow-Up – May 23, 2025


[Japan M&A] NTT To Buy Out SBI Sumishin Net Bank (7163) At a HUGE Price for Minorities

By Travis Lundy

  • Late Nov-2024, SBI Sumishin Net Bank (7163 JP) was trading ¥2,900, weekly mag Bunshun scooped a possible NTT Docomo deal. The stock popped, I was skeptical. It popped more.
  • At Q3 earnings, NTT seemed to downplay the possibility saying they wouldn’t overpay. SBI Sumshin fell. Then fell some more. 
  • Today we get a deal whereby NTT buys out SBI Holdings (8473 JP)‘s 34% stake, and minorities, and partners with Sumitomo Mitsui Trust. Then a side deal with SBI. 

[Quiddity Index] GMO (9449) Sub GMO Financial Gate (4051) Moves to TOPIX

By Travis Lundy


[Japan ECM] Financial Crossholders Offering Isuzu (7202) – Big Buyback Covers Most Of The Back End

By Travis Lundy

  • In line with the trend of financial institutions led by non-life insurers selling out of their cross-holdings, today we get an offering of shares held in Isuzu Motors (7202 JP)
  • Today we got an announcement of 29.28mm shares being offered by a dozen financial institutions and a greenshoe for 15% more. At a 10% discount from here it’s ¥57bn/US$400mm.
  • It is 16 days of ADV, which is big, but the company also announced a ¥50bn buyback from Pricing+6 to end of March 2026. That should stabilise things.

Isuzu Motors Placement – Relatively Small Deal Along with Buyback

By Sumeet Singh

  • A group of shareholders aims to raise around US$380m via selling around 4% of Isuzu Motors (7202 JP).
  • Being another cross-shareholding unwind in Japan, it shouldn’t carry much negative connotations, in our view.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

SBI Sumishin Net Bank (7163 JP): NTT’s (9432 JP) JPY4,900 Tender Offer a Done Deal

By Arun George

  • SBI Sumishin Net Bank (7163 JP) has recommended a tender offer from NTT (Nippon Telegraph & Telephone) (9432 JP) at JPY4,900 per share, a 23.0% premium to the last close.
  • Irrevocables from the two largest shareholders, representing a 68.38% ownership ratio, ensure a done deal as it exceeds the required 66.67% ownership ratio to pass the EGM share consolidation vote.
  • The offer is attractive compared to historical trading ranges and peer multiples. The tender offer runs from 30 May to 10 July (30 business days).

CIT Saves the World from Tariffs, but Not Mazda (7261)

By Michael Allen

  • Mazda leaped upward with other Auto companies following a Court of International Trade ruling that nullified Trump’s reciprocal tariffs but left auto tariffs at 25%.
  • The CIT has historically given presidents much more leeway on rules that the auto tariffs fall under, so challenges to these tariffs are less likely to succeed.
  • The tariff threat to Mazda is existential, and in our view, consensus forecasts have not even begun to appreciate this.

Nippon Steel (5401 JP): Navigating Decline at Home, Expanding Abroad

By Rahul Jain

  • Nippon Steel targets over 100 Mt capacity by 2030, focusing on global growth as Japan’s domestic demand shrinks.
  • It plans to acquire U.S. Steel for $14.9B and expand in India via AMNS joint ventures.
  • FY24 profit rose 36%, but export reliance, ESG lag, and U.S. deal hurdles pose risks.

Shift: Shift in Recruitment Policy Supports Margin Recovery; Further Upside

By Shifara Samsudeen, FCMA, CGMA

  • Shift’s share price has been up by more than 35% YTD driven by improved margins which saw a temporary decline due to Shift’s investment on HR and system reinforcement.
  • The company’s GPM reached an all-time high in 2QFY08/2025 while OPM has shown significant improvement driven by the company’s changes to recruitment policy that is aligned to utilisation rates.
  • Though Shift’s top line growth has slowed down, it’s not something to worry too much about as its new businesses and large-scale project wins should help revive top line growth.

Migalo Holdings (5535 JP) – Q4 Follow-Up – May 23, 2025

By Sessa Investment Research

  • On May 12, 2025, MIGALO HOLDINGS Inc. (hereafter, the Company) announced its FY2025/3 full-year earnings results.
  • Net sales increased 21.2% YoY to JPY 51,709 mn, and operating profit increased 8.5% YoY to JPY 2,713 mn. Results were solid overall, with surpassing the initial forecast of JPY 50,000 mn for sales and JPY 2,600 mn for operating profit.
  • ROE came in at 12.9%, exceeding its management benchmark of 12.0%. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: HDFC Bank, Sarda Energy & Minerals, Globus Spirits, Indusind Bank, Synergy Green Industries, Aster DM Healthcare Ltd, Bosch Ltd, ICICI Lombard General Insurance Company and more

By | Daily Briefs, India

In today’s briefing:

  • NIFTY Bank Index: Impact of the Forecast Methodology Change
  • Sarda Energy (SARDA IN): Power-Led Transition with Re-Rating Potential
  • HDFC Bank Tactical View: Inflection Point or Just a Pause?
  • Globus Spirits: Consumer Business Growth &  Manufacturing Stability
  • HDFC Bank (“HDFCB”): Steady Performance in Line with Expectation
  • A Deep Dive into SEBI’s IndusInd Bank Insider Trading Order
  • Synergy Green Industries Q4 FY25 Update: Capacity Expansion Fuels Strong FY25
  • 2025 High Conviction Update: Aster DM(ASTERDM IN)-Occupancy to Recover; Margin Improvement Continues
  • Bosch Limited: Shifting Gears Toward Intelligent and Sustainable Mobility
  • ICICI Lombard (ICICIGI IN) Vs. SBI Life (SBILIFE IN): A Statistical Pair Trade Opportunity


NIFTY Bank Index: Impact of the Forecast Methodology Change

By Brian Freitas

  • To reduce index concentration and the risk of market volatility and market manipulation, SEBI has recommended changes to the eligibility criteria for derivatives on non-benchmark indices.
  • The recommended changes will result in two inclusions to the NSE Nifty Bank Index (NSEBANK INDEX) along with large capping changes.
  • The inclusions and capping changes will result in an estimated one-way turnover of 17.05% and in a round-trip trade of INR 76.2bn (US$893m) in September.

Sarda Energy (SARDA IN): Power-Led Transition with Re-Rating Potential

By Rahul Jain

  • Sarda’s near-term growth will be driven by the full-year contribution from SKS Power, boosting earnings visibility.
  • The business mix is shifting structurally from steel to power, which now contributes over 60% of EBIT. Low leverage at <1x EV/EBITDA is a positive.
  • The recent weakness in spot power prices is seen as temporary; at 15x FY27 EV/EBITDA, the stock offers strong upside.

HDFC Bank Tactical View: Inflection Point or Just a Pause?

By Nico Rosti

  • HDFC Bank (HDFCB IN) is navigating a mix of positive growth indicators and emerging regulatory challenges but average 12-month target is ₹2,194, with estimates ranging from ₹1,627 to ₹2,793.
  • Consensus rating: predominantly “Buy” from major brokerages, including ICICI Securities and Motilal Oswal, citing strong loan growth and stable asset quality.
  • The stock’s strong fundamentals and growth outlook remain intact, but momentum has stalled in recent weeks following the sharp rally we correctly anticipated from January 14, 2025.

Globus Spirits: Consumer Business Growth &  Manufacturing Stability

By Sudarshan Bhandari

  • Globus Spirits continues its strategic pivot towards high-margin consumer business, with P&A revenue up 186% in FY25 and Regular & Others up 17%.
  • The manufacturing segment’s margins are stabilising due to favourable government ethanol policies and raw material availability, enhancing overall profitability.
  • This shift, coupled with significant investments in the key Uttar Pradesh market and near completion of major capex, positions the company for continued profitable growth, reinforcing a positive view.

HDFC Bank (“HDFCB”): Steady Performance in Line with Expectation

By Ankit Agrawal, CFA

  • In Q4FY25, deposits grew strong at 15.8% YoY. QoQ, average deposits grew by 3.1%. Time deposits led the growth while growth in CASA deposits was relatively muted.
  • In line with its stated strategy, HDFCB’s loan book has been growing slower than that of deposits to bring down the credit-deposit ratio. Average AUM grew 7.3% YoY in Q4FY25.
  • Credit-Deposit ratio is now at 96% vs 110% at merger. Going forward, the adjustment in credit-deposit ratio won’t be as steep, thus FY26 is expected to be a normalization year.

A Deep Dive into SEBI’s IndusInd Bank Insider Trading Order

By Nimish Maheshwari

  • SEBI’s order against IndusInd Bank’s ex-CEO and others reveals a 15-month deliberate delay in disclosing critical accounting discrepancies.
  • This exposes severe corporate governance failures, eroding investor trust due to alleged insider trading.
  • SEBI fined the company with the INR 20Crs. to IndusInd officials as well as also barred the senior officials from dealing in security market.

Synergy Green Industries Q4 FY25 Update: Capacity Expansion Fuels Strong FY25

By Sudarshan Bhandari

  • Synergy Green reported robust FY25 performance with 11% revenue growth and 224bps EBITDA margin expansion, driven by direct exports and gearboxes.  
  • Strong execution and margin improvement underscore operational efficiency, while a significant INR 187 crore capex addresses capacity constraints, crucial for future growth.
  • Performance validates the business model, but the delayed capex execution means FY26 growth will be heavily back-ended, requiring close monitoring of ramp-up.

2025 High Conviction Update: Aster DM(ASTERDM IN)-Occupancy to Recover; Margin Improvement Continues

By Tina Banerjee

  • Aster DM Healthcare Ltd (ASTERDM IN) reported 4% revenue decline in Kerala due to festivities, lower international patient, and leadership transition. Ramadan impact caused 2.5–3.0% of the revenue hit.
  • Going ahead, the company is eyeing for atleast mid-teens growth from Kerala cluster, with 7–8% will be with volumes and balance 7–8% will come from the ARPOB.  
  • Aster’s base business is on a stable growth path. Margin levers are intact. With QCIL merger synergies, the company aims for EBITDA margin of 23–24% in 3–4 years.

Bosch Limited: Shifting Gears Toward Intelligent and Sustainable Mobility

By Sreemant Dudhoria

  • Bosch Ltd (BOS IN) ‘s multiple technology innovations in mobility, consumer power goods and energy & building technology will drive future growth.
  • FY25 PBT grew by 17% YoY driven by increased sales in the off-highway segment and mobility aftermarket business.
  • Deserves a premium valuation for its commitment to innovation, digitalization, and sustainability. Trades at median historical valuation of 40x P/E on FY27e EPS.

ICICI Lombard (ICICIGI IN) Vs. SBI Life (SBILIFE IN): A Statistical Pair Trade Opportunity

By Gaudenz Schneider

  • The ICICI Lombard (ICICIGI IN) vs. SBI Life (SBILIFE IN) Price-Ratio has deviated more than two standard deviations from its one-year average, presenting a potential relative value opportunity.
  • The relative value opportunity can be implemented through stocks, derivatives, or as relative over-/underweights in a long only context.
  • This Insight discusses trade setup, statistical properties, factor exposure, and risk management strategies.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Samsung KODEX Semicon ETF, Otis Worldwide , Curtiss Wright, Tetra Tech Inc, Verisk Analytics, Watts Water Technologies A, Synergy Green Industries and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Clarifying the Universe for Key Korean Index Rebalancings in September
  • Otis CEO: Moving Billions Daily, Elevator Evolution, and Service Excellence
  • Curtiss-Wright: Commercial Aerospace Opportunities As A Key Growth Catalyst!
  • Tetra Tech: Will Its Investments In Infrastructure & Water Management Projects Yield Results…
  • Verisk Analytics: Adaptation to Market Conditions, M&A Focus & Other Major Developments!
  • Watts Water Technologies: Vertical Integration & U.S.-Based Manufacturing to Capitalize On Its Competitive Advantages In Manufacturing & Distribution!
  • Synergy Green Industries Q4 FY25 Update: Capacity Expansion Fuels Strong FY25


Clarifying the Universe for Key Korean Index Rebalancings in September

By Sanghyun Park

  • KRX sector indices use TMI as their universe, while KOSPI cap-tier indices use all KOSPI-listed stocks, creating a key difference in universe selection.
  • KRX sector indices rebalance annually after September expiry, using September TMI (reviewed end-July) as their universe—not the June version, despite common confusion.
  • Pre-Positioning is uncertain; market likely waits for August’s September TMI results before building positions. KOSPI cap indices use August review date, with similar flow patterns starting six weeks prior.

Otis CEO: Moving Billions Daily, Elevator Evolution, and Service Excellence

By In Good Company with Nicolai Tangen

  • Passenger experience is key for elevators, focusing on ride quality and safety
  • Elevators should prioritize moving people quickly and efficiently
  • The elevator industry is highly consolidated with few major competitors and regulations play a significant role in the industry

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Curtiss-Wright: Commercial Aerospace Opportunities As A Key Growth Catalyst!

By Baptista Research

  • Curtiss-Wright’s first quarter 2025 earnings results reveal a robust start to the year, driven by both increased sales and operational efficiency.
  • The company reported a 13% year-over-year increase in sales to $806 million, with an 11% rise on an organic basis.
  • This growth was primarily fueled by stronger-than-expected performance in the Aerospace and Defense (A&D) markets.

Tetra Tech: Will Its Investments In Infrastructure & Water Management Projects Yield Results…

By Baptista Research

  • The latest earnings for Tetra Tech presented a mix of positive developments and notable challenges, providing investors with a nuanced view of the company’s current financial health and strategic direction.
  • The quarter was extraordinary in terms of revenue and profitability, achieved despite the unexpected loss of the largest client, which marks a significant test for Tetra Tech’s client diversification strategy.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Verisk Analytics: Adaptation to Market Conditions, M&A Focus & Other Major Developments!

By Baptista Research

  • Verisk Analytics (Verisk) has demonstrated a positive start to 2025, with a notable performance in the first quarter.
  • The company saw double-digit growth in subscription revenues, contributing to an overall organic constant currency (OCC) revenue increase of 7.9%.
  • This growth was propelled by a 10.6% rise in subscription revenues, reflecting strength across multiple business units within the company.

Watts Water Technologies: Vertical Integration & U.S.-Based Manufacturing to Capitalize On Its Competitive Advantages In Manufacturing & Distribution!

By Baptista Research

  • Watts Water Technologies reported its first quarter results for 2025, which showed a mix of positive achievements and ongoing challenges.
  • The company experienced record operating income and operating margins, along with adjusted earnings per share.
  • Despite these results, organic sales declined by 2%, impacted by fewer shipping days and weakness in the European market.

Synergy Green Industries Q4 FY25 Update: Capacity Expansion Fuels Strong FY25

By Sudarshan Bhandari

  • Synergy Green reported robust FY25 performance with 11% revenue growth and 224bps EBITDA margin expansion, driven by direct exports and gearboxes.  
  • Strong execution and margin improvement underscore operational efficiency, while a significant INR 187 crore capex addresses capacity constraints, crucial for future growth.
  • Performance validates the business model, but the delayed capex execution means FY26 growth will be heavily back-ended, requiring close monitoring of ramp-up.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Isuzu Motors, SHEIN, Mazda Motor, The Pinkfong Company, Miniso, Globus Spirits, Build A Bear Workshop, Lands’ End Inc, Light & Wonder and more

By | Consumer, Daily Briefs

In today’s briefing:

  • [Japan ECM] Financial Crossholders Offering Isuzu (7202) – Big Buyback Covers Most Of The Back End
  • Isuzu Motors Placement – Relatively Small Deal Along with Buyback
  • Shein IPO: Hong Kong Yes, London No
  • CIT Saves the World from Tariffs, but Not Mazda (7261)
  • Initial Thoughts on The Pinkfong Company IPO (Creator of the Baby Shark Brand)
  • [Miniso(MNSO US, SELL, TP US$13.5) TP Change]: C1Q25 Review: Low Quality Expansion Bore Bitter Fruit
  • Globus Spirits: Consumer Business Growth &  Manufacturing Stability
  • BBW: 1Q Review: Impressive Q; Guide Right for the Times; Reiterate Buy, $58 PT
  • LE: 1Q Preview: Being Creative in Uncertain Times; Reiterate Buy, $20 PT
  • Light & Wonder’s Secret Weapon: Premium Games & A $1.4B Profit Target in Sight; But Is It Achievable?


[Japan ECM] Financial Crossholders Offering Isuzu (7202) – Big Buyback Covers Most Of The Back End

By Travis Lundy

  • In line with the trend of financial institutions led by non-life insurers selling out of their cross-holdings, today we get an offering of shares held in Isuzu Motors (7202 JP)
  • Today we got an announcement of 29.28mm shares being offered by a dozen financial institutions and a greenshoe for 15% more. At a 10% discount from here it’s ¥57bn/US$400mm.
  • It is 16 days of ADV, which is big, but the company also announced a ¥50bn buyback from Pricing+6 to end of March 2026. That should stabilise things.

Isuzu Motors Placement – Relatively Small Deal Along with Buyback

By Sumeet Singh

  • A group of shareholders aims to raise around US$380m via selling around 4% of Isuzu Motors (7202 JP).
  • Being another cross-shareholding unwind in Japan, it shouldn’t carry much negative connotations, in our view.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

Shein IPO: Hong Kong Yes, London No

By Douglas Kim

  • Shein announced it is planning for an IPO in Hong Kong in 2025. Shein tried to go public in London, but its attempt has essentially failed. 
  • Due to tariff war and ending de minimis for shipments from China and Hong Kong by the U.S. government, the valuation of Shein could decline to less than $50 billion.
  • Now, as long as the valuation is not excessive but reasonable, there could be a decent demand for this IPO of Shein in Hong Kong. 

CIT Saves the World from Tariffs, but Not Mazda (7261)

By Michael Allen

  • Mazda leaped upward with other Auto companies following a Court of International Trade ruling that nullified Trump’s reciprocal tariffs but left auto tariffs at 25%.
  • The CIT has historically given presidents much more leeway on rules that the auto tariffs fall under, so challenges to these tariffs are less likely to succeed.
  • The tariff threat to Mazda is existential, and in our view, consensus forecasts have not even begun to appreciate this.

Initial Thoughts on The Pinkfong Company IPO (Creator of the Baby Shark Brand)

By Douglas Kim

  • In this insight, we provide our initial thoughts on The Pinkfong Company IPO which is expected to be completed in KOSPI in 2H 2025.
  • The Pinkfong Company is the creator of the Baby Shark brand. Its original “Baby Shark Dance” is the most viewed Youtube video ever (15.9 billion views as of May 2025). 
  • The Pinkfong Company’s valuation was more than 1 trillion won in 2021 (Series B investment round). 

[Miniso(MNSO US, SELL, TP US$13.5) TP Change]: C1Q25 Review: Low Quality Expansion Bore Bitter Fruit

By Eric Wen

  • MNSO reported 1Q25 rev. in line with cons. but non-GAAP op. profit 17% below and GAAP net income 33% below cons, 
  • We view MNSO’s store expansion as being below its bar of quality. Downside risks were not fully priced in. Our 2025 revenue/net profit forecasts are 7.0%/8.2% below consensus;
  • We cut the TP from US$16 to US$13.5/ADS and keep the SELL rating.

Globus Spirits: Consumer Business Growth &  Manufacturing Stability

By Sudarshan Bhandari

  • Globus Spirits continues its strategic pivot towards high-margin consumer business, with P&A revenue up 186% in FY25 and Regular & Others up 17%.
  • The manufacturing segment’s margins are stabilising due to favourable government ethanol policies and raw material availability, enhancing overall profitability.
  • This shift, coupled with significant investments in the key Uttar Pradesh market and near completion of major capex, positions the company for continued profitable growth, reinforcing a positive view.

BBW: 1Q Review: Impressive Q; Guide Right for the Times; Reiterate Buy, $58 PT

By Small Cap Consumer Research

  • We are reiterating our Buy rating and $58 price target for Build-A-Bear Workshop and slightly lowering our EPS projections to account for the current tariff-driven environment, as the company announced material 1Q top and bottom line upside, driven by strong offerings, seasonal shifts and further gains in the higher margin franchising and third party segments.
  • Further, management continues to return capital to shareholders via share repurchases and quarterly dividends, while still maintaining a cash rich ($3.37 per share), debt free balance sheet.
  • That said, given the current uncertain economic environment, management, despite the 1Q upside, remained conservative in their guidance, reiterating FY25 revenue growth of mid single digits and reducing the pre-tax projection to $61 to $67 million.

LE: 1Q Preview: Being Creative in Uncertain Times; Reiterate Buy, $20 PT

By Small Cap Consumer Research

  • We are reiterating our Buy rating, price target and projections for Lands’ End with the company announcing 1QFY25 (April) results before the open on Thursday.
  • We believe in the key tenets of the Lands’ Ends story, from: 1) lowering discounting (and inventory); 2) shifting the product and customer mix to a younger, more fashion driven buyer who will purchase multi-item offerings; 3) expanding and shifting the product mix with higher-margin licensed categories; 4) continuing to expand the online marketplace offerings; 5) leveraging the company’s strong brand and ability to quickly respond to capture more business services contracts and 6) growing the international business via owned and licensed offerings.
  • That said, even before tariffs, the optics of 2025, with increased levels of licensed goods, would make this year a period of transition.

Light & Wonder’s Secret Weapon: Premium Games & A $1.4B Profit Target in Sight; But Is It Achievable?

By Baptista Research

  • Light & Wonder (LNW) has demonstrated resilient growth in its first quarter of 2025, reflective of a comprehensive strategy focused on product innovation, operational excellence, and a diversified gaming portfolio.
  • The company reported a 2% increase in consolidated revenue year-over-year, reaching $774 million, driven primarily by its gaming and iGaming segments.
  • The gaming division, which accounted for $495 million of the revenue, experienced growth across various business lines, notably in gaming operations, tables, and systems.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars